RSS2.0

Biogen Idec Announces Multiple Sclerosis Franchise and Pipeline Presentations at the European Committee for Treatment ...

Thursday, October 11, 2007

Biogen Idec ( Nachrichten ) (NASDAQ: BIIB) today announced that nearly 25 posters and symposia sponsored by the company will be presented at the 23 rd Congress of the European Committee for Treatment and Research of Multiple Sclerosis (ECTRIMS) in Prague, Czech Republic.
From: www.finanznachrichten.de

0 comments: